BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27529561)

  • 1. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Challenges and Opportunities.
    Heinisch T; Ward TR
    Acc Chem Res; 2016 Sep; 49(9):1711-21. PubMed ID: 27529561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond.
    Ward TR
    Acc Chem Res; 2011 Jan; 44(1):47-57. PubMed ID: 20949947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Enzymatic Cascades and Directed Evolution.
    Liang AD; Serrano-Plana J; Peterson RL; Ward TR
    Acc Chem Res; 2019 Mar; 52(3):585-595. PubMed ID: 30735358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking Symmetry: Engineering Single-Chain Dimeric Streptavidin as Host for Artificial Metalloenzymes.
    Wu S; Zhou Y; Rebelein JG; Kuhn M; Mallin H; Zhao J; Igareta NV; Ward TR
    J Am Chem Soc; 2019 Oct; 141(40):15869-15878. PubMed ID: 31509711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial metalloenzymes based on biotin-avidin technology for the enantioselective reduction of ketones by transfer hydrogenation.
    Letondor C; Humbert N; Ward TR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4683-7. PubMed ID: 15772162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin.
    Collot J; Gradinaru J; Humbert N; Skander M; Zocchi A; Ward TR
    J Am Chem Soc; 2003 Jul; 125(30):9030-1. PubMed ID: 15369356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial metalloenzymes: (strept)avidin as host for enantioselective hydrogenation by achiral biotinylated rhodium-diphosphine complexes.
    Skander M; Humbert N; Collot J; Gradinaru J; Klein G; Loosli A; Sauser J; Zocchi A; Gilardoni F; Ward TR
    J Am Chem Soc; 2004 Nov; 126(44):14411-8. PubMed ID: 15521760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial metalloenzymes for enantioselective catalysis based on the noncovalent incorporation of organometallic moieties in a host protein.
    Ward TR
    Chemistry; 2005 Jun; 11(13):3798-804. PubMed ID: 15761912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial transfer hydrogenases based on the biotin-(strept)avidin technology: fine tuning the selectivity by saturation mutagenesis of the host protein.
    Letondor C; Pordea A; Humbert N; Ivanova A; Mazurek S; Novic M; Ward TR
    J Am Chem Soc; 2006 Jun; 128(25):8320-8. PubMed ID: 16787096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial metalloenzymes for olefin metathesis based on the biotin-(strept)avidin technology.
    Lo C; Ringenberg MR; Gnandt D; Wilson Y; Ward TR
    Chem Commun (Camb); 2011 Nov; 47(44):12065-7. PubMed ID: 21959544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging artificial metalloenzymes for asymmetric hydrogenation reactions.
    Goralski ST; Rose MJ
    Curr Opin Chem Biol; 2022 Feb; 66():102096. PubMed ID: 34879303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual anchoring strategy for the localization and activation of artificial metalloenzymes based on the biotin-streptavidin technology.
    Zimbron JM; Heinisch T; Schmid M; Hamels D; Nogueira ES; Schirmer T; Ward TR
    J Am Chem Soc; 2013 Apr; 135(14):5384-8. PubMed ID: 23496309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Library design and screening protocol for artificial metalloenzymes based on the biotin-streptavidin technology.
    Mallin H; Hestericová M; Reuter R; Ward TR
    Nat Protoc; 2016 May; 11(5):835-52. PubMed ID: 27031496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacers.
    Skander M; Malan C; Ivanova A; Ward TR
    Chem Commun (Camb); 2005 Oct; (38):4815-7. PubMed ID: 16193124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spiers Memorial Lecture: Shielding the active site: a streptavidin superoxide-dismutase chimera as a host protein for asymmetric transfer hydrogenation.
    Igareta NV; Tachibana R; Spiess DC; Peterson RL; Ward TR
    Faraday Discuss; 2023 Aug; 244(0):9-20. PubMed ID: 36924204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flexibility of a biotinylated ligand in artificial metalloenzymes based on streptavidin--an insight from molecular dynamics simulations with classical and ab initio force fields.
    Panek JJ; Ward TR; Jezierska-Mazzarello A; Novic M
    J Comput Aided Mol Des; 2010 Sep; 24(9):719-32. PubMed ID: 20526651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designed evolution of artificial metalloenzymes: protein catalysts made to order.
    Creus M; Ward TR
    Org Biomol Chem; 2007 Jun; 5(12):1835-44. PubMed ID: 17551630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritin encapsulation of artificial metalloenzymes: engineering a tertiary coordination sphere for an artificial transfer hydrogenase.
    Hestericová M; Heinisch T; Lenz M; Ward TR
    Dalton Trans; 2018 Aug; 47(32):10837-10841. PubMed ID: 30019062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed Evolution of Artificial Metalloenzymes: A Universal Means to Tune the Selectivity of Transition Metal Catalysts?
    Reetz MT
    Acc Chem Res; 2019 Feb; 52(2):336-344. PubMed ID: 30689339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of strept(avidin)-based artificial metalloenzymes in organometallic catalysis.
    Mukherjee P; Maiti D
    Chem Commun (Camb); 2020 Dec; 56(93):14519-14540. PubMed ID: 33150893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.